micdotcom: On Monday, Martin Shkreli made headlines after his company hiked the price of Daraprim, a life-saving drug for AIDS patients, from $13.50 to $750 per pill. Shkreli cited it as a necessary business decision, but Twitter was having none of it.
micdotcom: On Monday, Martin Shkreli made headlines after his company hiked the price of Daraprim, a life-saving drug for AIDS patients, from $13.50 to $750 per pill. Shkreli cited it as a necessary business decision, but Twitter was having none of it.
micdotcom: On Monday, Martin Shkreli made headlines after his company hiked the price of Daraprim, a life-saving drug for AIDS patients, from $13.50 to $750 per pill. Shkreli cited it as a necessary business decision, but Twitter was having none of it.
micdotcom: On Monday, Martin Shkreli made headlines after his company hiked the price of Daraprim, a life-saving drug for AIDS patients, from $13.50 to $750 per pill. Shkreli cited it as a necessary business decision, but Twitter was having none of it.
micdotcom: On Monday, Martin Shkreli made headlines after his company hiked the price of Daraprim, a life-saving drug for AIDS patients, from $13.50 to $750 per pill. Shkreli cited it as a necessary business decision, but Twitter was having none of it.
micdotcom: On Monday, Martin Shkreli made headlines after his company hiked the price of Daraprim, a life-saving drug for AIDS patients, from $13.50 to $750 per pill. Shkreli cited it as a necessary business decision, but Twitter was having none of it.
micdotcom: On Monday, Martin Shkreli made headlines after his company hiked the price of Daraprim, a life-saving drug for AIDS patients, from $13.50 to $750 per pill. Shkreli cited it as a necessary business decision, but Twitter was having none of it.
micdotcom: On Monday, Martin Shkreli made headlines after his company hiked the price of Daraprim, a life-saving drug for AIDS patients, from $13.50 to $750 per pill. Shkreli cited it as a necessary business decision, but Twitter was having none of it.
